ISOTECHNIKA INC. CONSOLIDATED BALANCE SHEET  
As at August 31,1999
(Unaudited)
 
 
1999
1998
ASSETS
 
Current
Cash
$ 211,512
-
Accounts Receivable
500,375
595,592
Inventories
498,827
150,684
Prepaid expenses and deferred costs
17,813
403,379

  1,228,527
1,149,655
 
Capital assets, net
802,041
987,789
Patent and trademark costs
751,114
525,284
Deferred start-up costs
-
51,352

 
$ 2,781,682
$2,714,080



LIABILITIES
 
Current
Bank indebtedness
-
$ 349,113
Accounts payable and accrued liabilities
1,126,881
1,372,849
Promissory Note
20,000
200,000
Current portion of obligations under capital leases
67,544
108,191
Current portion of long-term debt
-
76,286

  1,214,425
2,106,439
 
Obligations under capital leases
147,206
69,138
Long-term debt
75,000
75,000

 
1,436,631
2,250,577

 
Shareholders' Equity
Share capital Issued 27,258,376 shares (1997 - 24,218,376)
10,171,178
7,069,854
Deficit
(8,826,127)
(6,606,351)

  1,345,051
463,503

  $ 2,781,682
$ 2,714,080



ISOTECHNIKA INC. CONSOLIDATED STATEMENT OF OPERATIONS AND DEFICIT  
For the nine months ended August 31, 1999
(Unaudited)
 
 
1999
1998
Revenue
Product sales and contract analysis
$ 1,281,692
$ 1,022,613
Licensing, royalties and other
528,106
490,515
Interest
77,846
51,674

  1,887,644
1,564,802

 
Expenses
Research and development
1,334,497
1,472,483
Selling and administration
1,011,491
1,249,839
Cost of product sales and contract analysis
862,244
655,473
Depreciation & amortization
218,565
309,836
Interest on long-term debt
7,786
26,150

 
3,434,583
3,713,781

 
(1,546,939)
(2,148,979)
 
Other Income
Research and development tax credits
1,096,246
210,277

 
Net loss for the period
(450,693)
(1,938,702)
Deficit, beginning of period
(8,375,434)
(4,667,649)

 

Deficit, end of period
$ (8,826,127)
$ (6,606,351)



Loss per share
$ 0.02
$ (0.08)



ISOTECHNIKA INC. CONSOLIDATED STATEMENT OF CHANGES IN FINANCIAL POSITION  
For the nine months ended August 31, 1999
(Unaudited)
 
 
1999
1998
Operating activities
 
Net loss for the period
$ (450,693)
$ (1,938,702)
Item not affecting cash
Depreciation & amortization
218,565
309,836
Loss on disposal of capital assets
-
1,391
Net change in non-cash components of working capital
(766,254)
(368,211)

  (998,382)
(1,995,686)
 
Investing activities
 
Purchase of capital assets
(171,005)
(217,338)
Proceeds on sale of capital assets
-
215,000
Scientific research and development tax credit related to capital assets
38,903
71,568
Patent costs
(111,884)
(91,219)

  (243,986)
(21,989)
 
Financing activities
 
Proceeds on issuance of promissory notes
-
200,000
Repayment of promissory notes and loans payable
(1,522,000)
-
Obligations under capital leases
152,075
112,400
Repayment of capital leases
(54,500)
(129,686)
Repayment of long-term debt
-
(41,562)
Issuance of share capital, net of share issue costs
3,101,324
1,296,686

  1,676,899
1,437,838

 
Increase (decrease) in cash
434,531
(579,837)
 
Cash position, beginning of period
(223,019)
230,724

Cash position, end of period
$ 211,512
$ (349,113)


Cash position is defined as term deposits, treasury bills and money market fund less bank indebtedness.
 
Approved on behalf of the Board
Doug Walker, Director      Joseph Koziak, Director